Self-monitoring of blood pressure (BP) outside pregnancy is increasingly popular with patients and health care professionals. Around 1:3 people self-monitor 1 and it is more accurate than BP readings taken in clinic.
Standfirst: Guidelines encourage the use of self-monitoring of blood pressure in pregnancy, and research suggests that women prefer it. But the blood pressure monitoring in pregnancy group (BUMP) explain that our enthusiasm may run ahead of the evidence. They outline what is known and call for better understanding before self-monitoring is implemented.
Self-monitoring of blood pressure (BP) outside pregnancy is increasingly popular with patients and health care professionals. Around 1:3 people self-monitor 1 and it is more accurate than BP readings taken in clinic. 2 Anecdotal reports in the UK suggest that self-monitoring in pregnancy is commonplace, although few robust data exist to quantify this accurately.
Around two thirds of women diagnosed with gestational hypertension were already self-monitoring according to a Canadian pilot survey. 3 Another small, Canadian survey found that 78% of obstetricians used self-o ito i g to he k fo white oat hype te sio WCH in women whom they diagnosed with hypertension in pregnancy, rather than ambulatory blood pressure measurement (ABPM; wearing a small digital blood pressure monitor that measures BP repeatedly over a 24-hour period). 4 BP Guidelines recommend home monitoring for women with chronic hypertension and poorly controlled BP and for women with gestational hypertension, for example 2013 ACOG (American College of Obstetricians and Gynaecologists) guidelines, so it is likely that the practice will become more common. 5 The American Heart Association (AHA)/ American Society of Hypertension (ASH)/ Preventive Cardiovascular Nurses Association (PCNA) joint statement 6 and ESH guidelines have highlighted the importance and potential of self-monitored BP measurement and describe it as theo eti ally ideal fo o ito i g changes in BP du i g p eg a y . 7 If shown to be acceptable to women and accurate for screening and monitoring of normal and high BP in pregnancy, greater use of home monitoring could augment clinic based monitoring significantly. It may allow for the reorganisation of antenatal care. Availability of self-monitored results could allow health care professionals to spend more time on responding appropriately to BP results rather than actually performing monitoring. Alternatively, self-monitoring could integrate effectively with a group prenatal care model, wherein women do their own readings in the clinic and these are reviewed by the midwife. 8 There are reasons why self-monitoring may or may not be a good idea in pregnancy (see box 1). The aim of this article is to explain what is known about the evidence for self-monitoring and suggest a way forward. We extracted key studies from Medline searches up to March 2014, without limiting by publication date or language. We additionally searched the BHS 9 and dabl 10 websites (which both summarise BP monitor validation studies published in peer reviewed journals) to identify relevant validation studies.
The scale of the problem
Hypertensive disorders during pregnancy (box 2) are a leading cause of maternal mortality worldwide. 11 They are associated with fetal growth restriction, low birth weight, preterm delivery, respiratory distress syndrome, and admission to neonatal intensive care. 12 In women who have died from pre-eclampsia, substandard care has been identified in 46% of maternal deaths and 65% of fetal deaths. 13 In these cases, different management could reasonably have been expected to alter the outcome; in particular failures to identify and act on known risk factors at booking appointments and to recognise a d espo d to sig s a d sy pto s f o 20 weeks' gestatio have been noted. This suggests that health care professionals could do better and may provide a basis for change from the status quo.
One in ten women have raised BP (>140/90mmHg), with or without proteinuria, during pregnancy worldwide, 14 and the proportion of women with high BP, and risk factors for high BP, is increasing. In the USA, for example, the percentage of women who are obese (BMI > 30) or overweight (BMI > 25) has increased almost 60% in the last 30 years -there is a three-fold increase in the risk of pre-eclampsia associated with obesity. 15, 16 The number of pregnant women over 40 in the UK has more than doubled in the last 24 years, 17 and advanced maternal age is associated with around a 50% increase of pre-eclampsia. 18 Pre-eclampsia manifests long before clinical symptoms, 19, 20 and there is evidence that women in the UK develop the condition between antenatal visits. In 383 confirmed cases of eclampsia, 323 (85%) women had been seen by a doctor or midwife in the week before their first convulsion, but at that point 36 (11%) had neither hypertension nor proteinuria, 32 (10%) had proteinuria but no hypertension, and 71 (22%) had hypertension alone. 21 Current guidelines recommend BP monitoring at routine antenatal visits with i eased f e ue y fo those at highe isk, 22 but comprehensive systematic reviews have not identified any screening test (including those based on demographic characteristics, biomarkers or ultrasound screening) that have sufficient accuracy or cost-effectiveness to introduce into clinical practice, and consequently intermittent BP monitoring in a clinic setting remains the mainstay of pre-eclampsia detection in antenatal care. 23 Earlier identification of rising BP amongst asymptomatic women could improve targeting of resources for close monitoring and outcomes. Such measurement provides a potential benefit of selfmonitoring between clinic appointments.
Blood pressure in pregnancy
Clinic measurements are more vulnerable to error compared to out-of-office monitoring; at home more measurements can be taken and white coat hypertension is avoided. The variability of BP is heightened in pregnancy, 24 and debate continues about what constitutes normal blood pressure in pregnancy and how this may change by trimester. Clinic measurements could lead to unnecessary monitoring or missed opportunities to detect raised BP, though there are no reliable data to describe this currently. Data from ambulatory monitoring suggest that outcomes in those with white coat hypertension in pregnancy are similar to those with normotension.
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Will women self-monitor?
We know pregnant women are willing to undertake repeated self-measurements, comply with monitoring schedules 26 and are able to accurately record BP data. 27 It does not appear to increase anxiety, 28 even when using more complex telemonitoring equipment. 29, 30 Clinicians promoting self-monitoring report being encouraged by wo e 's co-operation, competence and genuine desire to participate in their own healthcare.
Error! Bookmark not defined.31,32 Over 98% of women with hypertension in pregnancy reported liking being involved in their BP management. 3 Self-monitoring of BP in pregnancy is more acceptable to pregnant women than more frequent clinic visits, 33 hospitalisation 30 or ambulatory monitoring. 34, 35 In a study of 81 healthy pregnant women, 95% found self-monitoring of BP (using Omron HEM705CP) acceptable compared to 78% 24-hour ABPM. 36 Home monitoring caused less discomfort, and rarely interfered with activities or disturbed sleep.
Is self-monitoring accurate?
There is a scarcity of home monitors validated and deemed accurate for use in pregnancy and in pre-eclampsia, in contrast to the number validated for use in the general population. Specific validation of monitors in a pregnant population is important because several monitors have in the past failed validation, mostly due to falsely low readings. 37, 38 Five monitors have been validated as being accurate within pre-defined margins by one of the three most widely used protocols produced by, respectively, the British Hypertension Society, 39 the Association for the Advancement of Medical Instrumentation Standard, 40 or the International Protocol of the European Society of Hypertension, 41 for home use in pregnancy. 42, 43, 44, 45, 46 Even validated monitors may not be accurate for all pregnant women; for example, though obesity is an established risk factor for pre-eclampsia, 47 when the accuracy of three commercially available devices was tested on 55 pregnant women with upper arm circumference >35cm, none was accurate. 48 
How should self-monitoring be done?
In essential hypertension, a minimum of three days and ideally seven days selfmonitoring is currently recommended, although the evidence underlying this is not particularly compelling. 49 Conclusions from ambulatory monitoring in pregnancy suggest that a level of 135/85 mmHg best predicts future pregnancy-induced hypertension, but these threshold values have not been established firmly. 50, 51 Clear reference thresholds for self-monitoring have not been established to diagnose hypertension in pregnancy. 49, 52 Little data are available comparing clinic thresholds with self-monitored BP in pregnancy and the studies they are drawn from have significant methodological weaknesses.
At a more basic level incomplete understanding of normal blood pressure in pregnancy means that any monitoring in pregnancy is challenging. BP changes through the trimesters, falling and then rising again, thus a woman may have a BP that starts at 100/70 mmHg, falls in mid-trimester to 90/60 mmHg and then rises to 135/85 mmHg (for example), but is still considered within normal limits (<140/90mmHg by clinic measurement), despite the rise from booking BP. It is unclear whether monitoring frequency should change if there is a marked increment in blood pressure without crossing this threshold of 140/90 mmHg. 53 Despite this, at present only the 140/90mmHg threshold is accepted for all trimesters. 26 Women with pre-existing hypertension may have more unpredictable BP in pregnancy due to medication changes to stop treatment or change to safer medicines in early pregnancy.
In the absence of clear evidence, there is little guidance on how often BP should be measured. The US guidelines recommend that in women with hypertension before p eg a y the diag osis should e o fi ed y ultiple easu e e ts a d ay incorporate home or other out-of-offi e BP eadi gs , ut the e is o state e t concerning what this means practically, for example how frequently BP should be measured. 54 NICE guidelines on hypertension in pregnancy conclude that research is needed to determine the optimal frequency and timing of measurement and on the role of screening for proteinuria in women who have existing hypertension and those who may develop pre-eclampsia. 55 
Are pregnancy outcomes different if self-monitoring is used?
It is not known whether self-monitoring will alter outcomes. In the UK, a pilot RCT included a weekly self-monitoring regime in eighty low risk women combined with a reduced antenatal visit schedule. 56 A larger trial did not go ahead, perhaps because the predicted number of low risk women required was 10,000. A future trial may be better to focus on the role of self-monitoring in a higher risk group where fewer numbers would be needed and women would be more likely to gain benefit. 57 Few data exist on the safety of self-monitoring, but there are conflicting reports regarding how well women follow instructions from health care professionals.
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Bookmark not defined., 58 In one small study, women who recorded their own BP responded appropriately by contacting healthcare professionals when repeated readings were persistently raised. 59 However, researchers found 10 out of 21 pregnant women in another study 42 had poor understanding of the instructions given and the importance of alerting midwives in the Day Assessment Unit (DAU) when their BP was raised above a threshold. Issues included language barriers and personal/ work commitments.
The bottom line
Self-monitoring of BP appears to be feasible and acceptable to pregnant women. It might add to the efficacy of modern antenatal care. However, new evidence is required to establish the precise place of self-monitoring during and after pregnancy (see box 3). If self-monitoring is or becomes widespread, research may be difficult to undertake. We believe that until the evidence base is considerably stronger, further implementation of self-monitoring of BP in pregnancy, at least formally by the NHS, should be delayed. Regardless, the trend towards self-monitoring is set to increase, and it is important to acknowledge this and respect people's choices. We suggest that GPs and midwives at least need to be sensitive to this, and could enquire whether women in their care are self-monitoring, and if so would they like to share the results or receive any help interpreting them. They should also discuss the uncertainty around how the results are best interpreted.
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